Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ)

Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ) — VMCI valuation read

Across 120 indicators, Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ) lands at VMCI 42/100. The Healthcare sector median is 50, so the 8-point below-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on 002873.SZ in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, 002873.SZ trades at 25.0x earnings, 39% above the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 9.0% trails the Healthcare median (10.0%) by 1.0pp. On Risk, net debt to EBITDA of 0.2x leaves covenant headroom for 002873.SZ on the trailing balance sheet.

002873.SZ fell 2.6% over the trailing 7 days, with a +1.8% read on a 30-day basis.